α2-HS Glycoprotein/Fetuin, a Transforming Growth Factor-β/Bone Morphogenetic Protein Antagonist, Regulates Postnatal Bone Growth and Remodeling

This publication has 54 references indexed in Scilit:

• BMP-5 deficiency alters chondrocytic activity in the mouse proximal tibial growth plate
  Bone, 1999
• Decreased bone mass and bone elasticity in mice lacking the transforming growth factor-β1 gene
  Published by Elsevier ,1998
• Concentration of Transforming Growth Factor Beta in Human Bone Tissue: Relationship to Age, Menopause, Bone Turnover, and Bone Volume
  Journal of Bone and Mineral Research, 1998
• Murine α-Macroglobulins Demonstrate Divergent Activities as Neutralizers of Transforming Growth Factor-β and as Inducers of Nitric Oxide Synthesis
  Published by Elsevier ,1996
• Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosis-like phenotype.
  The Journal of cell biology, 1996
• Betaglycan can act as a dual modulator of TGF-beta access to signaling receptors: mapping of ligand binding and GAG attachment sites
  The Journal of cell biology, 1994
• Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease
  Nature, 1992
• Increased Osteoclast Development After Estrogen Loss: Mediation by Interleukin-6
  Science, 1992
• The Nature of Bone Morphogenetic Protein (BMP) Fractions Derived from Bovine Bone Matrix Gelatin
  Published by Wolters Kluwer Health ,1982
• Serum concentration of human alpha 2 HS glycoprotein during the inflammatory process: evidence that alpha 2 HS glycoprotein is a negative acute-phase reactant.
  Journal of Clinical Investigation, 1979